Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: In vitro study of isolated rat heart model

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 2, 2004, Pages 270-275

  Yamazaki, Kazuhiro ^a   Miwa, Senri ^a   Ueda, Kunihiro ^a   Tanaka, Seigo ^a   Toyokuni, Shinya ^a   Unimonh, Oriyanhan ^a   Nishimura, Kazunobu ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cardioplegia; Heart surgery; Ischemic reperfusion injury; Myocardial protection; PARS Poly(ADP ribose) synthetase inhibitor; Reactive oxygen species (ROS)

Indexed keywords

3 AMINOBENZAMIDE; CREATINE KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STANDARDIZATION;

ANIMALS; APOPTOSIS; BENZAMIDES; CARDIAC SURGICAL PROCEDURES; CARDIOPLEGIC SOLUTIONS; DISEASE MODELS, ANIMAL; DNA; ENZYME INHIBITORS; HEART; HEART ARREST, INDUCED; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NAD; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 3543051144     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.04.044     Document Type: Article

References (25)

1. Tortolani A.J., Powell S.R., Misik V., Weglicki W.B., Pogo G.J., Kramer J. Detection of alkoxyl and carbon-centered free radicals in coronary sinus blood from patients undergoing elective cardioplegia. Free Radic Biol Med. 14:1993;421-426
2. Schmitt J.P., Schroder J., Schunkert H., Birnbaum D.E., Aebert H. Role of apoptosis in myocardial stunning after open surgery. Ann Thorac Surg. 73:2002;1229-1235
3. Rhun L.Y., Kirkland J.B., Shah G.M. Cellular responses to DNA damage in the absence of poly(ADP-ribose) polymerase. Biochem Biophys Res Commun. 245:1998;1-10
4. Szabo C., Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci. 19:1998;287-298
5. Tokime T., Ueda K., Nozaki K., Kikuchi H. Enhanced poly(ADP-ribosyl) action after focal ischemia in rat brain. J Cerebral Blood Flow Metab. 18:1998;991-997
6. Liaudet L., Szabo A., Soriano F.G., Zingarelli B., Szabo C., Salzman A.L. Poly(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock. 14:2000;134-141
7. Halmosi R., Berente Z., Osz E., Toth K., Literati-Nagi P., Sumegi B. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion- induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol Pharmacol. 59:2001;1497-1505
8. Zingarelli B., Cuzzocrea S., Zsengeller Z., Salzman A.L., Szabo C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase. Cardiovasc Res. 36:1997;205-215
9. Bowes J., Ruetten H., Martorana P.A., Stockhausen H., Thiemermann C. Reduction of myocardial reperfusion injury by an inhibitor of poly(ADP-ribose) synthetase in the pig. Eur J Pharmacol. 359:1998;143-150
10. Bowes J., McDonald M.C., Piper J., Thiemermann C. Inhibitors of poly(ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. Cardiovasc Res. 41:1999;126-134
11. Faro R., Toyoda Y., McCully J.D., Jagtap P., Szabo E., Virag L., Bianchi C., Levitsky S., Szabo C., Sellke F.W. Myocardial protection by PJ34, a novel potent poly(ADP-ribose) synthetase inhibitor. Ann Thorac Surg. 73:2002;575-581
12. Bergmeyer U.H. Nicotinamide-adenine dinucleotides (NAD, NADP, NADH, NADPH). Spectrophotometric and fluorometric methods. Methods Enzymatic Anal. 4:1994;2045-2051
13. Kasai H., Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12:1984;2137-2145
14. Toyokuni S. Reactive oxygen spicies-induced molecular damage and its application in pathology. Pathol Int. 49:1999;91-102
15. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida I., Hirai H., Ochi H., Osawa T. Quantitative immunohistchemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 76:1997;365-374
16. Zeweier J.L., Flaherty J.T., Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 84:1987;1404-1408
17. McCord J.M. Free radicals and myocardial ischemia: overview and outlook. J Free Radical Biol Med. 4:1988;9-14
18. Bowes J., Thiemermann C. Effects of inhibitors of the activity of poly(ADP-ribose) synthetase on the liver injury caused by ischemia-reperfusion: a comparison with radical scavengers. Br J Pharmacol. 124:1998;1254-1260
19. Miwa S., Toyokuni S., Nishina T., Nomoto T., Hiroyasu M., Nishimura K., Komeda M. Spaciotemporal alteration of 8-hydroxy-2′-deoxyguanosine levels in cardimyocytes after myocardial infarction in rats. Free Radic Res. 36:2002;853-858
20. Aebert H., Kirchner S., Keyser A., Birnbaum D.E., Holler E., Andreesen R., Eissner G. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg. 18:2000;589-593
21. Banasik M., Komura H., Shinoyama M., Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono (ADP-ribosyl) transferase. J Biol Chem. 267:1992;1569-1575
22. Utsumi H., Elkind M.M. Inhibitors of poly(ADP-ribose) synthesis inhibit the two types of repair of potentially lethal damage. Int J Radiat Oncol Biol Phys. 29:1994;577-578
23. Shall S., Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model. Mutat Res. 460:2000;1-15
24. Chang C.H., Lin P.J., Chu Y., Lee Y.S. Impaired endothelium dependent relaxation after cardiac global ischemia and reperfusion: role of warm blood cardioplegia. J Am Coll Cardiol. 29:1997;681-687
25. Roth M., Kraus B., Scheffold T., Reuthebuch O., Klovekorn W.P., Bauer E.P. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg. 120:2000;642-650